Cancer-type oatp1b3-V1 is a functional plasma membrane transporter mediating increased uptake of chemotherapeutics in vitro and in vivo
Type 2 diabetes mellitus (T2DM) is the predominant form, accounting for over 90% of all diabetes cases globally
Licensed medical supervision: Your care should be directed by a licensed clinician who reviews your full medical history, medications, and contraindications before prescribing
Higher-frequency dosing: For advanced schedules, split the daily total across two or more injections rather than one large volume
PSPeptides manufactures all GHK-Cu peptide domestically, reducing transit time and exposure to temperature variations that can degrade peptide integrity before it reaches your laboratory
When 2.5 mg/mL is commonly cited Peptides with wider dose ranges semaglutide (0.25 mg to 2.4 mg), tirzepatide (2.5 mg to 15 mg), retatrutide are commonly reconstituted at 2.5 mg/mL